NCT01572480 2026-03-10
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
4 trialsNCT03031730 2026-02-10
Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
National Cancer Institute (NCI)
Phase 1 Terminated
NCT01402284 2021-03-02
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01658904 2016-06-01
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated